![Robin D. Campbell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robin D. Campbell
Presidente presso Aptitude Medical Systems, Inc.
Posizioni attive di Robin D. Campbell
Società | Posizione | Inizio | Fine |
---|---|---|---|
Aptitude Medical Systems, Inc.
![]() Aptitude Medical Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Aptitude Medical Systems, Inc. provides biotechnical research services. The company was founded by Jinpeng Wang, Qiang Gong and Scott Ferguson in 2011 and is headquartered in Santa Barbara, CA. | Presidente | 01/12/2011 | - |
Acelot, Inc. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Robin D. Campbell
Precedenti posizioni note di Robin D. Campbell
Società | Posizione | Inizio | Fine |
---|---|---|---|
PFENEX INC. | Direttore/Membro del Consiglio | 24/09/2014 | 01/10/2020 |
Independent Dir/Board Member | 24/09/2014 | 01/10/2020 | |
SYMBIO PHARMACEUTICALS LIMITED | Direttore/Membro del Consiglio | 01/04/2018 | 01/03/2019 |
Naryx Pharma, Inc.
![]() Naryx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Naryx Pharma, Inc. developd products for the treatment of chronic sinusitis. Its products were focused on inhaled, nebulizer, intranasal drug formulations. Its products include Sybryx, which is used for the treatment of chronic sinusitis. The company focused on development of inhaled, nebulized, and intranasal drug formulations. The company was founded in 1999 and was headquartered in Carpinteria, CA. | Amministratore Delegato | 01/01/2004 | 01/01/2008 |
Presidente | 01/01/2004 | 01/01/2008 | |
AMGEN INC. | Corporate Officer/Principal | 01/01/1989 | 01/01/2002 |
Kirin-Amgen, Inc.
![]() Kirin-Amgen, Inc. Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Kirin-Amgen, Inc. is a pharmaceutical company that manufactures drugs and provides licensing. The company is based in Thousand Oaks, CA. Kirin-Amgen was acquired by Amgen, Inc. from Kirin Holdings Co., Ltd. on January 29, 2018 for $810 million. | Presidente | 01/01/1997 | 01/01/2000 |
SEQUUS Pharmaceuticals, Inc.
![]() SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Direttore/Membro del Consiglio | 01/01/1998 | 01/01/1999 |
Ciba-Geigy Corp. | Corporate Officer/Principal | - | - |
Formazione di Robin D. Campbell
Wake Forest School of Medicine | Doctorate Degree |
The University of North Carolina at Charlotte | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 11 |
Giappone | 2 |
Posizioni
Director/Board Member | 4 |
President | 2 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 8 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
AMGEN INC. | Health Technology |
SYMBIO PHARMACEUTICALS LIMITED | Health Technology |
Aziende private | 7 |
---|---|
Ciba-Geigy Corp. | Health Technology |
SEQUUS Pharmaceuticals, Inc.
![]() SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Health Technology |
Naryx Pharma, Inc.
![]() Naryx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Naryx Pharma, Inc. developd products for the treatment of chronic sinusitis. Its products were focused on inhaled, nebulizer, intranasal drug formulations. Its products include Sybryx, which is used for the treatment of chronic sinusitis. The company focused on development of inhaled, nebulized, and intranasal drug formulations. The company was founded in 1999 and was headquartered in Carpinteria, CA. | Health Technology |
Kirin-Amgen, Inc.
![]() Kirin-Amgen, Inc. Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Kirin-Amgen, Inc. is a pharmaceutical company that manufactures drugs and provides licensing. The company is based in Thousand Oaks, CA. Kirin-Amgen was acquired by Amgen, Inc. from Kirin Holdings Co., Ltd. on January 29, 2018 for $810 million. | Health Technology |
Pelican Inc
![]() Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
Acelot, Inc. | |
Aptitude Medical Systems, Inc.
![]() Aptitude Medical Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Aptitude Medical Systems, Inc. provides biotechnical research services. The company was founded by Jinpeng Wang, Qiang Gong and Scott Ferguson in 2011 and is headquartered in Santa Barbara, CA. | Commercial Services |
- Borsa valori
- Insiders
- Robin D. Campbell
- Esperienza